Published in Oncogene on May 21, 2007
Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat Protoc (2009) 3.14
Modeling inducible human tissue neoplasia identifies an extracellular matrix interaction network involved in cancer progression. Cancer Cell (2009) 1.43
DMBA/TPA treatment is necessary for BCC formation from patched deficient epidermal cells in Ptch(flox/flox)CD4Cre(+/-) mice. J Invest Dermatol (2014) 1.41
Arsenic exposure in utero exacerbates skin cancer response in adulthood with contemporaneous distortion of tumor stem cell dynamics. Cancer Res (2008) 1.40
Hypoxia-inducible factor-1alpha suppresses squamous carcinogenic progression and epithelial-mesenchymal transition. Cancer Res (2009) 1.15
Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis. Mol Carcinog (2010) 1.12
Polycyclic aromatic hydrocarbons as skin carcinogens: comparison of benzo[a]pyrene, dibenzo[def,p]chrysene and three environmental mixtures in the FVB/N mouse. Toxicol Appl Pharmacol (2012) 0.98
The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification. Int J Cancer (2010) 0.95
A keratin 15 containing stem cell population from the hair follicle contributes to squamous papilloma development in the mouse. Mol Carcinog (2012) 0.90
MyD88 and its divergent toll in carcinogenesis. Trends Immunol (2013) 0.88
CLIC4 is a tumor suppressor for cutaneous squamous cell cancer. Carcinogenesis (2012) 0.86
Use of a TGFbeta type I receptor inhibitor in mouse skin carcinogenesis reveals a dual role for TGFbeta signaling in tumor promotion and progression. Carcinogenesis (2010) 0.83
Tumor suppressor and oncogene actions of TGFbeta1 occur early in skin carcinogenesis and are mediated by Smad3. Mol Carcinog (2009) 0.83
Transforming growth factor beta1 enhances tumor promotion in mouse skin carcinogenesis. Carcinogenesis (2010) 0.81
The Role of TGFβ Signaling in Squamous Cell Cancer: Lessons from Mouse Models. J Skin Cancer (2012) 0.80
The homeoprotein DLX3 and tumor suppressor p53 co-regulate cell cycle progression and squamous tumor growth. Oncogene (2015) 0.78
Meis1 regulates epidermal stem cells and is required for skin tumorigenesis. PLoS One (2014) 0.78
Differentiated State of Initiating Tumor Cells Is Key to Distinctive Immune Responses Seen in H-Ras(G12V)-Induced Squamous Tumors. Cancer Immunol Res (2017) 0.75
Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ (1993) 14.37
Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell (1980) 8.10
Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol (1999) 5.58
Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Network. Pediatrics (1991) 4.02
Prevalence of glaucoma in the west of Ireland. Br J Ophthalmol (1993) 3.42
Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ (2001) 3.38
Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell (1981) 2.72
Criterion validity and reliability of the SF-36 in a population sample. Qual Life Res (1994) 2.68
Transplacental effects of 3'-azido-2',3'-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys. J Natl Cancer Inst (1997) 2.61
A survey of transformation markers in differentiating epidermal cell lines in culture. Cancer Res (1980) 2.53
Evaluation of acute physiology and chronic health evaluation III predictions of hospital mortality in an independent database. Crit Care Med (1998) 2.44
Calcium regulation of cell-cell contact and differentiation of epidermal cells in culture. An ultrastructural study. Exp Cell Res (1983) 2.43
c-fos is required for malignant progression of skin tumors. Cell (1995) 2.39
Portability issues for a structured clinical vocabulary: mapping from Yale to the Columbia medical entities dictionary. J Am Med Inform Assoc (1996) 2.24
Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med (1999) 2.21
Isolation and utilization of epidermal keratinocytes for oncogene research. Methods Enzymol (1995) 2.10
Lessons learned from a pilot implementation of the UMLS information sources map. J Am Med Inform Assoc (1995) 2.05
Promoter sequences of the human transforming growth factor-beta 1 gene responsive to transforming growth factor-beta 1 autoinduction. J Biol Chem (1989) 1.97
Synthetic peptides corresponding to keratin subunits elicit highly specific antibodies. J Biol Chem (1984) 1.96
Mouse skin cells resistant to terminal differentiation associated with initiation of carcinogenesis. Nature (1981) 1.96
FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis (1993) 1.95
Altered differentiation of mouse epidermal cells treated with retinyl acetate in vitro. Exp Cell Res (1974) 1.94
Telephone assessment of illness by practicing pediatricians. J Pediatr (1976) 1.93
Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo. Genes Dev (1998) 1.88
An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue. Nature (1986) 1.86
Tumour promoter induces anchorage independence irreversibly. Nature (1979) 1.83
Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation. EMBO J (1993) 1.78
Ten years portal hypertensive surgery at Emory. Results and new perspectives. Ann Surg (1982) 1.78
Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis. J Pediatr (1985) 1.73
Serologic diagnosis of epidemic typhus fever. Am J Epidemiol (1977) 1.73
Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy. Proc Natl Acad Sci U S A (1987) 1.71
Reconstitution of hair follicle development in vivo: determination of follicle formation, hair growth, and hair quality by dermal cells. J Invest Dermatol (1993) 1.66
A pilot project in molecular cancer epidemiology: determination of benzo[a]pyrene--DNA adducts in animal and human tissues by immunoassays. Carcinogenesis (1982) 1.66
Malignant conversion of mouse skin tumours is increased by tumour initiators and unaffected by tumour promoters. Nature (1983) 1.65
The role of the general practitioner in the community care of people with HIV infection and AIDS: a comparative study of high- and low-prevalence areas in England. Br J Gen Pract (1998) 1.65
Keratin gene expression in mouse epidermis and cultured epidermal cells. Proc Natl Acad Sci U S A (1983) 1.64
Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development. Am J Pathol (1997) 1.62
Regulated expression of differentiation-associated keratins in cultured epidermal cells detected by monospecific antibodies to unique peptides of mouse epidermal keratins. Differentiation (1987) 1.62
Retinoic acid induces transforming growth factor-beta 2 in cultured keratinocytes and mouse epidermis. Cell Regul (1989) 1.61
Anonymous living liver donation: donor profiles and outcomes. Am J Transplant (2010) 1.60
Primary pulmonary hypertension between inflammation and cancer. Chest (1998) 1.57
Optimized conditions for the growth of human epidermal cells in culture. J Invest Dermatol (1980) 1.57
Coordinate changes in gene expression which mark the spinous to granular cell transition in epidermis are regulated by protein kinase C. J Cell Biol (1993) 1.54
Phorbol esters stimulate DNA synthesis and ornithine decarboxylase activity in mouse epidermal cell cultures. Nature (1976) 1.54
Protein kinase Cdelta targets mitochondria, alters mitochondrial membrane potential, and induces apoptosis in normal and neoplastic keratinocytes when overexpressed by an adenoviral vector. Mol Cell Biol (1999) 1.51
Quantitation of benzo(a)pyrene-deoxyguanosine adducts by radioimmunoassay. Cancer Res (1980) 1.49
Involvement of protein kinase C delta (PKCdelta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCdelta. J Biol Chem (2000) 1.49
Developmental issues in child health psychology. Am Psychol (1986) 1.46
Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin. Carcinogenesis (1987) 1.44
Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts. Cancer Res (1988) 1.44
Divergent responses in epidermal basal cells exposed to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res (1982) 1.44
Altered growth and differentiation of cultured mouse epidermal cells infected with oncogenic retrovirus: contrasting effects of viruses and chemicals. Cancer Res (1983) 1.43
Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc Natl Acad Sci U S A (1993) 1.40
In vivo regulation of murine hair growth: insights from grafting defined cell populations onto nude mice. J Invest Dermatol (1993) 1.39
Functions of the POU domain genes Skn-1a/i and Tst-1/Oct-6/SCIP in epidermal differentiation. Genes Dev (1997) 1.39
Evaluation of children's sexual behaviors and incorporation of base rates in judgments of sexual abuse. Child Abuse Negl (1995) 1.38
The measurement of cisplatin-DNA adduct levels in testicular cancer patients. Carcinogenesis (1988) 1.38
Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma. Genes Dev (1994) 1.37
Expression of an oncogenic rasHa gene in murine keratinocytes induces tyrosine phosphorylation and reduced activity of protein kinase C delta. J Biol Chem (1993) 1.37
Induction of papillomas with a high probability of conversion to malignancy. Carcinogenesis (1985) 1.36
Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy. J Clin Invest (1986) 1.35
Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C delta. J Biol Chem (1996) 1.34
p53-mediated transcriptional activity increases in differentiating epidermal keratinocytes in association with decreased p53 protein. Oncogene (1995) 1.34
Antibodies elicited against cis-diamminedichloroplatinum(II)-modified DNA are specific for cis-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro. Proc Natl Acad Sci U S A (1982) 1.33
Induction of long-term survival of hamster heart xenografts in rats. Transplantation (1991) 1.33
Antigenic relationships between the typhus and spotted fever groups of rickettsiae. Am J Epidemiol (1978) 1.31
Studies on the mechanism of skin tumor promotion. Cancer Res (1970) 1.29
Detection and prevention of treatable visual failure in general practice: room for improvement? Br J Gen Pract (1994) 1.28
Minority enrichment programs at the New Jersey Medical School: 26 years in review. Acad Med (1999) 1.28
Increased expression of pAKT is associated with radiation resistance in cervical cancer. Br J Cancer (2006) 1.28
Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-ras(Ha) oncogene but does not block in vitro keratinocyte responses to oncogenic ras. Cancer Res (1997) 1.27
p53 and tumor necrosis factor alpha regulate the expression of a mitochondrial chloride channel protein. J Biol Chem (1999) 1.27
Early signals for keratinocyte differentiation: role of Ca2+-mediated inositol lipid metabolism in normal and neoplastic epidermal cells. Carcinogenesis (1988) 1.26
Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene or N-methyl-N'-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice. Cancer Res (1981) 1.26
Detection of carcinogen-DNA adducts by radiommunoassay. Nature (1977) 1.26
Specific epidermal protein markers are modulated during calcium-induced terminal differentiation. J Cell Biol (1983) 1.24
The syndrome of primary aldosteronism. Am J Med (1970) 1.24
Epidermal cell culture. Transplant Proc (1980) 1.24
Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study. Ann Oncol (2007) 1.23
Transforming growth factor beta 1 suppresses genomic instability independent of a G1 arrest, p53, and Rb. Cancer Res (1996) 1.23
Subunit structure of the mouse epidermal keratin filament. Biochim Biophys Acta (1979) 1.21
Measurement of benzo(a)pyrene-DNA adducts by enzyme immunoassays and radioimmunoassay. Cancer Res (1981) 1.20
Genetic deletion of p21WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis. Cancer Res (1999) 1.19
Evaluation of platinum-DNA adduct levels relative to known prognostic variables in a cohort of ovarian cancer patients. Cancer Res (1990) 1.19
Bactericidal activity and mechanism of action of AZD5847, a novel oxazolidinone for treatment of tuberculosis. Antimicrob Agents Chemother (2013) 1.18